U.S. Medical Gases and Equipment Market Size, Share & Forecast 2026–2032

ID: MR-11210 | Published: November 2026
Download PDF Sample

Report Highlights

  • ✓Country: United States
  • ✓Market: Medical Gases and Equipment
  • ✓Market Size 2024: USD 6.8 billion
  • ✓Market Size 2032: USD 10.4 billion
  • ✓CAGR: 5.4%
  • ✓Base Year: 2025
  • ✓Forecast Period: 2026–2032
Market Growth Chart
Want Detailed Insights - Download Sample
Analyst Findings and Recommendations
FINDING 01
Concentrators Erode Cylinder Volumes: Home oxygen concentrators are displacing cylinder deliveries in U.S. home care. Inogen and Drive DeVilbiss sell devices through Medicare channels, eroding refill revenue for Linde and Air Liquide. Suppliers owning device distribution will capture the margin shift.
FINDING 02
Helium Shortage Headlines Overstated: Helium shortage headlines imply MRI rationing, but sealed low-helium magnets from Philips and GE HealthCare now need under one liter. The real exposure lies in Qatari and Algerian import concentration, not hospital demand.
ANALYST RECOMMENDATION

Analyst Recommendation — Lock Bulk Oxygen Contracts Now: Hospital procurement heads should renegotiate bulk liquid oxygen contracts with Linde or Air Liquide before third-quarter 2026. Multi-year pricing with volume floors protects against cryogenic capacity tightening and concentrator cost shifts.

The U.S. Position in the Global Medical Gases and Equipment Supply Chain

The United States is largely self-sufficient in medical oxygen but a net importer of medical devices and specialty gases. Domestic air separation units, concentrated along the Gulf Coast and the Ohio River corridor, supply most hospital oxygen within a few hundred miles of production. Helium is the critical exception, as the country draws a material share of supply from Qatar and Algeria while domestic output from Texas and Kansas fields has declined since federal reserve sales.

Device imports flow chiefly from Mexico, Germany, Ireland and China, with Mexican plants supplying disposable circuits, tubing and respiratory consumables under USMCA duty-free treatment. Exports remain modest, centred on oxygen concentrators and regulators shipped to Canada and Latin America. The country functions as a demand anchor and design hub for respiratory equipment rather than a bulk gas exporter, and its clinical standards shape global product specifications.

Growth Drivers Shaping U.S. Medical Gas and Equipment Trade

Chronic respiratory disease and an ageing Medicare population are lifting oxygen therapy volumes, with COPD and sleep apnea diagnoses rising steadily. Hospitals are converting cylinder-dependent sites to onsite oxygen generation, pulling demand toward pressure swing adsorption equipment from fabricators such as Chart Industries. This shift raises domestic capital goods output while reducing the bulk cylinder tonnage moved by road.

Home care is the second driver, as Medicare coverage for stationary and portable concentrators sustains device shipments from Inogen and Drive DeVilbiss Healthcare. Domestic assembly of concentrator components in Mexico and selected U.S. sites is growing to hedge tariff exposure. Third, post-pandemic reshoring of disposable airway products, backed by federal stockpile procurement, is expanding U.S. plant capacity for anesthesia circuits and gas delivery tubing.

Supply Chain Risks and Trade Barriers in U.S. Medical Gases

Helium import dependence exposes hospital imaging and cryogenic supply to shipping and geopolitical disruption, since Qatari cargoes transit the Strait of Hormuz. Oxygen production is energy-intensive, so electricity price spikes at Gulf Coast plants feed directly into delivered cost. Cylinder logistics also suffer from a shortage of licensed hazardous-materials drivers, lengthening delivery windows for rural critical access hospitals.

Trade barriers are tightening on equipment. Section 301 tariffs on Chinese medical goods raised duties on items such as syringes, gloves and certain respiratory components, while the 2025 Section 232 investigation into medical devices adds further uncertainty. Mexico's supply base depends on USMCA rules of origin, and peso volatility alters component pricing for suppliers invoicing in dollars.

Trade and Investment Opportunities in U.S. Medical Gases and Equipment

Onsite oxygen generation outsourcing offers an entry point for industrial gas groups and infrastructure investors. Hospital systems increasingly sign build-own-operate contracts with Linde and Air Liquide, creating long-dated, inflation-linked revenue. Foreign gas groups seeking U.S. healthcare exposure can acquire regional home-care distributors, which carry Medicare-reimbursed recurring revenue.

Import substitution in disposable respiratory consumables is commercially attractive for Mexico-based contract manufacturers seeking U.S. capacity. Nearshoring capital is flowing into Monterrey and Tijuana device clusters, where a U.S. buyer can source compliant tubing and circuits within days by truck. Helium recovery systems for MRI sites represent a smaller but growing equipment niche for specialized fabricators.

Market at a Glance

MetricValue
Market Size 2024USD 6.8 billion
Market Size 2032USD 10.4 billion
Growth Rate (CAGR)5.4%
Most Critical Decision FactorSecure bulk oxygen and helium supply contracts with cryogenic capacity guarantees
Largest RegionSouth Region
Competitive StructureConsolidated oligopoly in gases; fragmented in equipment

Leading Market Participants

  • Linde plc
  • Air Liquide
  • Air Products and Chemicals
  • Matheson Tri-Gas
  • Chart Industries
  • Vyaire Medical
  • Drive DeVilbiss Healthcare
  • Inogen
  • ResMed
  • Philips Respironics

Regulatory and Trade Policy Environment for Medical Gases

Medical gases are regulated as drugs by the FDA under the Federal Food, Drug, and Cosmetic Act, requiring USP monograph compliance and approved labeling. Gas delivery equipment falls under device classifications in 21 CFR Part 868 for anesthesia and respiratory devices. Hospital piping and outlets must meet NFPA 99 and Joint Commission standards, creating a compliance layer that favors established gas suppliers.

Trade policy is shaped by USMCA, which provides duty-free treatment for qualifying Mexican medical goods, and by Section 301 duties on Chinese products. Section 232 national security reviews of medical devices remain a live tariff risk. Reimbursement sits with CMS, whose durable medical equipment competitive bidding program reshapes pricing for home oxygen and concentrators, while CFIUS review applies to foreign acquisitions of sensitive healthcare assets.

U.S. Medical Gases and Equipment Supply Chain Outlook to 2032

By 2032, onsite generation and concentrators will reduce the share of bulk cylinder tonnage in U.S. oxygen supply, shifting logistics toward fewer, larger industrial gas plants. Helium scarcity will push MRI makers further toward sealed, cryogen-free magnets, shrinking per-unit helium consumption. Digital cylinder tracking and remote monitoring will become standard in hospitals procuring from Linde, Air Liquide and Matheson Tri-Gas.

Trade flows will tilt toward Mexico as nearshoring accelerates device assembly, while Chinese component exposure declines under Section 301 pressure. Comparative advantage will favor suppliers that integrate gas, device and service contracts, since they capture recurring revenue across the care continuum. The U.S. will remain a net importer of devices but gain value share through design, software and reimbursement-linked services.

Frequently Asked Questions

Supply is anchored by domestic air separation plants on the Gulf Coast and in the Ohio River corridor, with cylinders and bulk liquid moved by road. Hospitals are increasingly shifting to onsite generation to reduce delivery dependence.
The U.S. relies on imports from Qatar and Algeria for a material share of helium, so shipping routes through the Strait of Hormuz carry direct risk. Cryogen-free MRI systems are reducing per-unit helium demand across hospitals.
Mexico, Germany, Ireland and China are the leading sources of imported medical devices and consumables. Mexican plants benefit from duty-free treatment under USMCA when rules of origin are met.
USMCA preserves duty-free trade for qualifying Mexican goods, encouraging nearshoring of disposables and components. Section 301 duties on Chinese medical products push buyers to diversify supplier bases.
New capacity should be sited near high-density hospital clusters in the South and Midwest to minimize delivery distance. Proximity to reliable low-cost electricity is essential because oxygen production is energy-intensive.

Market Segmentation

By Product Type
  • Medical Oxygen
  • Medical Air
  • Nitrous Oxide
  • Carbon Dioxide
  • Gas Delivery Equipment
By End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Home Healthcare
  • Long-Term Care Facilities
  • Diagnostic Imaging Centers
By Supply Model
  • Cylinder and Bulk Delivery
  • Onsite Generation
  • Pipeline Distribution
  • Sealed Equipment Exchange

Table of Contents

Chapter 01 Methodology and Scope
1.1 Research Methodology
1.2 Scope and Definitions
1.3 Data Sources
Chapter 02 Executive Summary
2.1 Report Highlights
2.2 Market Size and Forecast 2024-2032
Chapter 03 U.S. Medical Gases and Equipment - Market Analysis
3.1 Market Overview
3.2 Growth Drivers
3.3 Restraints
3.4 Opportunities
Chapter 04 Product Type Insights
4.1 Medical Oxygen
4.2 Medical Air
4.3 Nitrous Oxide
4.4 Carbon Dioxide
4.5 Others
Chapter 05 End User Insights
5.1 Hospitals
5.2 Ambulatory Surgical Centers
5.3 Home Healthcare
5.4 Long-Term Care Facilities
5.5 Others
Chapter 06 Supply Model Insights
6.1 Cylinder and Bulk Delivery
6.2 Onsite Generation
6.3 Pipeline Distribution
6.4 Others
Chapter 07 Competitive Landscape
7.1 Market Players
7.2 Leading Market Participants
7.2.1 Linde plc
7.2.2 Air Liquide
7.2.3 Air Products and Chemicals
7.2.4 Matheson Tri-Gas
7.2.5 Chart Industries
7.2.6 Vyaire Medical
7.2.7 Drive DeVilbiss Healthcare
7.2.8 Inogen
7.2.9 ResMed
7.2.10 Philips Respironics
7.3 Regulatory Environment
7.4 Outlook

Research Framework and Methodological Approach

Information
Procurement

Information
Analysis

Market Formulation
& Validation

Overview of Our Research Process

MarketsNXT follows a structured, multi-stage research framework designed to ensure accuracy, reliability, and strategic relevance of every published study. Our methodology integrates globally accepted research standards with industry best practices in data collection, modeling, verification, and insight generation.

1. Data Acquisition Strategy

Robust data collection is the foundation of our analytical process. MarketsNXT employs a layered sourcing model.

Secondary Research
  • Company annual reports & SEC filings
  • Industry association publications
  • Technical journals & white papers
  • Government databases (World Bank, OECD)
  • Paid commercial databases
Primary Research
  • KOL Interviews (CEOs, Marketing Heads)
  • Surveys with industry participants
  • Distributor & supplier discussions
  • End-user feedback loops
  • Questionnaires for gap analysis

Analytical Modeling and Insight Development

After collection, datasets are processed and interpreted using multiple analytical techniques to identify baseline market values, demand patterns, growth drivers, constraints, and opportunity clusters.

2. Market Estimation Techniques

MarketsNXT applies multiple estimation pathways to strengthen forecast accuracy.

Bottom-up Approach

Country Level Market Size
Regional Market Size
Global Market Size

Aggregating granular demand data from country level to derive global figures.

Top-down Approach

Parent Market Size
Target Market Share
Segmented Market Size

Breaking down the parent industry market to identify the target serviceable market.

Supply Chain Anchored Forecasting

MarketsNXT integrates value chain intelligence into its forecasting structure to ensure commercial realism and operational alignment.

Supply-Side Evaluation

Revenue and capacity estimates are developed through company financial reviews, product portfolio mapping, benchmarking of competitive positioning, and commercialization tracking.

3. Market Engineering & Validation

Market engineering involves the triangulation of data from multiple sources to minimize errors.

01 Data Mining

Extensive gathering of raw data.

02 Analysis

Statistical regression & trend analysis.

03 Validation

Cross-verification with experts.

04 Final Output

Publication of market study.

Client-Centric Research Delivery

MarketsNXT positions research delivery as a collaborative engagement rather than a static information transfer. Analysts work with clients to clarify objectives, interpret findings, and connect insights to strategic decisions.